Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis

PURPOSE: To report the first patient with ocular toxoplasmosis treated with a slow-release biodegradable intravitreal clindamycin implant. OBSERVATIONS: A 39-year-old human immunodeficiency virus (HIV)-positive woman with recurrent toxoplasmic retinochoroiditis and vitritis for whom oral medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorge, Rodrigo, Coelho, Igor Neves, Silva-Cunha, Armando, Fernandes Cunha, Gabriella Maria, Scott, Ingrid U., Fialho, Silvia Ligório, Furtado, João Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085661/
https://www.ncbi.nlm.nih.gov/pubmed/33981913
http://dx.doi.org/10.1016/j.ajoc.2021.101093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085661/
https://www.ncbi.nlm.nih.gov/pubmed/33981913
http://dx.doi.org/10.1016/j.ajoc.2021.101093

Ejemplares similares